CN108704109A - 一种治疗痤疮的中药组合物及其制作方法 - Google Patents
一种治疗痤疮的中药组合物及其制作方法 Download PDFInfo
- Publication number
- CN108704109A CN108704109A CN201811008923.6A CN201811008923A CN108704109A CN 108704109 A CN108704109 A CN 108704109A CN 201811008923 A CN201811008923 A CN 201811008923A CN 108704109 A CN108704109 A CN 108704109A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- radix
- acne
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 56
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 49
- 206010000496 acne Diseases 0.000 title claims abstract description 49
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title abstract description 5
- 239000004098 Tetracycline Substances 0.000 claims abstract description 29
- 229960002180 tetracycline Drugs 0.000 claims abstract description 29
- 229930101283 tetracycline Natural products 0.000 claims abstract description 29
- 235000019364 tetracycline Nutrition 0.000 claims abstract description 29
- 150000003522 tetracyclines Chemical class 0.000 claims abstract description 29
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 25
- 229960000282 metronidazole Drugs 0.000 claims abstract description 24
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 claims abstract description 24
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 23
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 22
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 22
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims abstract description 22
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims abstract description 22
- 240000009138 Curcuma zedoaria Species 0.000 claims abstract description 22
- 241000545744 Hirudinea Species 0.000 claims abstract description 22
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 22
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 22
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 22
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 claims abstract description 22
- 229960002256 spironolactone Drugs 0.000 claims abstract description 22
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 20
- 229940079593 drug Drugs 0.000 claims abstract description 10
- 239000006071 cream Substances 0.000 claims abstract description 8
- 239000002245 particle Substances 0.000 claims description 28
- 241000245665 Taraxacum Species 0.000 claims description 21
- 239000002775 capsule Substances 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 14
- 239000006187 pill Substances 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 235000009508 confectionery Nutrition 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 235000012907 honey Nutrition 0.000 claims description 7
- 238000007873 sieving Methods 0.000 claims description 7
- 239000007921 spray Substances 0.000 claims description 7
- 238000009495 sugar coating Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 235000014676 Phragmites communis Nutrition 0.000 claims description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 1
- 229910052737 gold Inorganic materials 0.000 claims 1
- 239000010931 gold Substances 0.000 claims 1
- 229910052709 silver Inorganic materials 0.000 claims 1
- 239000004332 silver Substances 0.000 claims 1
- 235000014375 Curcuma Nutrition 0.000 abstract description 17
- 244000164480 Curcuma aromatica Species 0.000 abstract description 17
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract description 17
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract description 17
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract description 17
- 235000019509 white turmeric Nutrition 0.000 abstract description 17
- 206010061218 Inflammation Diseases 0.000 abstract description 5
- 208000027418 Wounds and injury Diseases 0.000 abstract description 5
- 210000002374 sebum Anatomy 0.000 abstract description 4
- 210000003205 muscle Anatomy 0.000 abstract description 3
- 240000001949 Taraxacum officinale Species 0.000 abstract description 2
- 206010052428 Wound Diseases 0.000 abstract description 2
- 230000032823 cell division Effects 0.000 abstract description 2
- 230000008929 regeneration Effects 0.000 abstract description 2
- 238000011069 regeneration method Methods 0.000 abstract description 2
- 230000028327 secretion Effects 0.000 abstract description 2
- 230000006641 stabilisation Effects 0.000 abstract description 2
- 238000011105 stabilization Methods 0.000 abstract description 2
- 230000001954 sterilising effect Effects 0.000 abstract description 2
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 2
- 238000005469 granulation Methods 0.000 abstract 1
- 230000003179 granulation Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 24
- 210000004369 blood Anatomy 0.000 description 18
- 239000008280 blood Substances 0.000 description 17
- 210000003491 skin Anatomy 0.000 description 16
- 210000002784 stomach Anatomy 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 230000010415 tropism Effects 0.000 description 9
- 210000001015 abdomen Anatomy 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 231100000241 scar Toxicity 0.000 description 7
- 244000061508 Eriobotrya japonica Species 0.000 description 6
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 241000186429 Propionibacterium Species 0.000 description 6
- 210000001732 sebaceous gland Anatomy 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 239000003053 toxin Substances 0.000 description 6
- 231100000765 toxin Toxicity 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 230000004224 protection Effects 0.000 description 5
- 206010000077 Abdominal mass Diseases 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 241000193880 Demodex folliculorum Species 0.000 description 4
- 239000009636 Huang Qi Substances 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
- 241000700647 Variola virus Species 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 206010040882 skin lesion Diseases 0.000 description 4
- 231100000444 skin lesion Toxicity 0.000 description 4
- 241001061264 Astragalus Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010044565 Tremor Diseases 0.000 description 3
- 235000006533 astragalus Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000003163 gonadal steroid hormone Substances 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 210000004233 talus Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 210000005239 tubule Anatomy 0.000 description 3
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- 208000020154 Acnes Diseases 0.000 description 2
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 2
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000006374 Uterine Cervicitis Diseases 0.000 description 2
- 229960002478 aldosterone Drugs 0.000 description 2
- 230000003255 anti-acne Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 206010008323 cervicitis Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 201000007094 prostatitis Diseases 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 229960003604 testosterone Drugs 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- 208000004881 Amebiasis Diseases 0.000 description 1
- 208000008710 Amebic Dysentery Diseases 0.000 description 1
- 206010001986 Amoebic dysentery Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 208000003014 Bites and Stings Diseases 0.000 description 1
- 206010006500 Brucellosis Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- MBYXEBXZARTUSS-QLWBXOBMSA-N Emetamine Natural products O(C)c1c(OC)cc2c(c(C[C@@H]3[C@H](CC)CN4[C@H](c5c(cc(OC)c(OC)c5)CC4)C3)ncc2)c1 MBYXEBXZARTUSS-QLWBXOBMSA-N 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 241000533849 Gleditsia Species 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241001263448 Mycetozoa Species 0.000 description 1
- 206010028470 Mycoplasma infections Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 240000005001 Paeonia suffruticosa Species 0.000 description 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 244000234609 Portulaca oleracea Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 206010067268 Post procedural infection Diseases 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 208000034712 Rickettsia Infections Diseases 0.000 description 1
- 206010061495 Rickettsiosis Diseases 0.000 description 1
- AUVVAXYIELKVAI-UHFFFAOYSA-N SJ000285215 Natural products N1CCC2=CC(OC)=C(OC)C=C2C1CC1CC2C3=CC(OC)=C(OC)C=C3CCN2CC1CC AUVVAXYIELKVAI-UHFFFAOYSA-N 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000767839 Semiaquilegia adoxoides Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241000589973 Spirochaeta Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 241000255632 Tabanus atratus Species 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 241001502500 Trichomonadida Species 0.000 description 1
- 208000005448 Trichomonas Infections Diseases 0.000 description 1
- 206010044620 Trichomoniasis Diseases 0.000 description 1
- 235000006085 Vigna mungo var mungo Nutrition 0.000 description 1
- 240000005616 Vigna mungo var. mungo Species 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 201000004308 chancroid Diseases 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000013507 chronic prostatitis Diseases 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 229960000452 diethylstilbestrol Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- AUVVAXYIELKVAI-CKBKHPSWSA-N emetine Chemical compound N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@@H]1CC AUVVAXYIELKVAI-CKBKHPSWSA-N 0.000 description 1
- 229960002694 emetine Drugs 0.000 description 1
- AUVVAXYIELKVAI-UWBTVBNJSA-N emetine Natural products N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@H]1CC AUVVAXYIELKVAI-UWBTVBNJSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229960005280 isotretinoin Drugs 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 208000007865 relapsing fever Diseases 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Insects & Arthropods (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明属于一种治疗痤疮的中药组合物及其制作方法,所述治疗痤疮的中药组合物由包括以下重量份数的原料制成:四环素10‑20份,灭滴灵片10‑20份,螺内酯10‑20份,金银花15‑25份,野菊花15‑25份,枇杷叶10‑20份,黄芩17‑27份,天丁18‑28份,天葵子18‑28份,红花10‑20份,桃仁15‑25份,水蛭15‑25份,虻虫10‑20份,三棱17‑27份,莪术17‑27份,葛根15‑25份,甘草5‑15份,蒲公英25‑35份。通过选料、粉碎、制膏、制粒步骤,制得治疗痤疮的中药组合物。本发明中各原料配比合适,所选用的中药物质量上乘稳定,中西药结合的方式,能迅速深入肌肤深处,促进细胞分裂再生,激发细胞活力,从根本上解决皮脂分泌旺盛的现象,愈合面皰伤口,消炎杀菌,无痕除去暗疮,让肌肤嫩白光滑,紧致无痕,恢复如初。
Description
技术领域
本发明属于医药保健领域,具体涉及一种治疗痤疮的中药组合物及其制作方法。
背景技术
痤疮是毛囊与皮脂腺的一种慢性炎症性皮肤病。多发于青春期男女,好发于面部或胸背部等皮脂腺丰富的部位。临床表现以丘疹、粉刺、脓疮、结节或囊肿等多形性皮损为特点。对青少年的心里和社交影响很大。
痤疮的发生,主要与皮脂分泌过多,毛囊皮脂腺导管堵塞,细菌感染和炎症反应等因素密切相关。进入青春期后,人体内雌性激素,特别是睾酮水平迅速增高,促进皮脂腺发育并产生大量皮脂。同时毛囊皮脂腺导管角化异常,造成导管阻塞。皮脂排出障碍,形成角质栓即微粉刺。毛囊中多种微生物尤其是痤疮丙酸杆菌大量繁殖,产生的脂酶分解皮脂,生成游离脂肪酸,同时趋化炎症细胞和介质,最终诱导并加重炎症反应。
现代医学治疗本病,外用:常用维A酸乳膏、过氧化苯甲酰、克林霉素、硫磺洗剂等。内服:首选四环素治疗,也常用异维A酸、抗雄性激素如乙烯雌酚,或烫皮激素、物理疗法、激光疗法等。洗衣治疗效果不是很理想,疗效很长,一般6-12个月,特别是结节、囊肿、瘢痕的皮损是治疗,效果不是很理想。
发明内容
本发明提供了一种治疗痤疮的中药组合物及其制作方法,从临床医疗用药需求及中医组方辩证原则出发,所选用的中药物质量上乘稳定,中西药结合的方式,能迅速深入肌肤深处,促进细胞分裂再生,激发细胞活力,从根本上解决皮脂分泌旺盛的现象,愈合面皰伤口,消炎杀菌,无痕除去暗疮,让肌肤嫩白光滑,紧致无痕,恢复如初。
为解决现有的技术问题,本发明采用的技术方案如下:
一种治疗痤疮的中药组合物,所述治疗痤疮的中药组合物由包括以下重量份数的原料制成:四环素10-20份,灭滴灵片10-20份,螺内酯10-20份,金银花15-25份,野菊花15-25份,枇杷叶10-20份,黄芩17-27份,天丁18-28份,天葵子18-28份,红花10-20份,桃仁15-25份,水蛭15-25份,虻虫10-20份,三棱17-27份,莪术17-27份,葛根15-25份,甘草5-15份,蒲公英25-35份。
优选的,所述治疗痤疮的中药组合物由包括以下重量份数的原料制成:四环素12-18份,灭滴灵片12-18份,螺内酯12-18份,金银花17-23份,野菊花17-23份,枇杷叶12-18份,黄芩17-27份,天丁20-26份,天葵子20-26份,红花12-18份,桃仁17-23份,水蛭17-23份,虻虫12-18份,三棱19-25份,莪术19-25份,葛根17-23份,甘草7-13份,蒲公英27-33份。
优选的,所述治疗痤疮的中药组合物由包括以下重量份数的原料制成:四环素15份,灭滴灵片15份,螺内酯15份,金银花20份,野菊花20份,枇杷叶15份,黄芩22份,天丁23份,天葵子23份,红花15份,桃仁20份,水蛭20份,虻虫15份,三棱22份,莪术22份,葛根20份,甘草10份,蒲公英30份。
一种治疗痤疮的中药组合物的制作方法包括以下步骤:
(1)选料:选取干净、品质优良的四环素,灭滴灵片,螺内酯,金银花,野菊花,枇杷叶,黄芩,天丁,天葵子,红花,桃仁,水蛭,虻虫,三棱,莪术,葛根,甘草,蒲公英按配比分别称量;
(2)粉碎:将步骤(1)称量后原料分别粉碎,过120-140目滤网过筛;
(3)制膏:将步骤(2)中筛制的混合物加水煎煮2-3次,合并煎液、过滤、滤液浓缩成75℃时相对密度为1.2-1.8的稠膏;
(4)制粒:将步骤(3)的稠膏分离纯化、干燥,制成颗粒;将所述颗粒混匀,填充胶囊内即制得胶囊剂;或者将所述颗粒喷加炼蜜、混匀,制成小丸即制成丸剂;或者将所述颗粒压制成片剂,包糖衣,即制成片剂。
四环素片的主要成分为四环素,四环素的作用机制是与核蛋白体的30S亚单位结合,从而阻止氨酰基-tRNA同核糖核蛋白体结合,为广谱抑菌剂,高浓度时具杀菌作用。四环素片对革兰氏阳性菌、阴性菌、立克次体、滤过性病毒、螺旋体属乃至原虫类都有抑制作用,是一种广谱抗菌素,对结核菌、变形菌等则无效。因此,四环素片对于立克次体病、支原体属感染、回归热、布鲁菌病、霍乱、兔热病、鼠疫、软下疳等具有治疗效果。痘痘丙酸杆菌是导致痘痘的一种重要因素,与此同时痘痘丙酸杆菌属于革兰氏阳性菌,因此四环素可治疗痘痘。
灭滴灵片有强大的杀灭滴虫作用为治疗滴虫病的首选药物。可用于治疗阿米巴痢和阿米巴肝脓肿,疗效与依米丁相仿。本品有抗厌氧菌作用,可用于治疗厌氧杆菌引起的产后盆腔炎、败血症、牙周炎等。还可用于治疗贾第氏鞭毛虫病、酒糟鼻。用于阑尾、结肠手术、妇产科手术,可降低或避免手术感染。
螺内酯为人工合成的甾体化合物,一种低效利尿剂,其结构与醛固酮相似,为醛固酮的竞争性抑制剂。由于本药仅作用于远曲小管和集合管,对肾小管其他各段无作用,故利尿作用较弱。另外,本药对肾小管以外的醛固酮靶器官也有作用。
金银花性味甘,寒;归经归肺、心、胃经;主治清热解毒,凉散风热。用于痈肿疔疮,喉痹,丹毒,热毒血痢,风热感冒,温病发热;用于外感风热或温病初起。银花甘寒,既清气分热,又能清血分热,且在清热之中又有轻微宣散之功,所以能治外感风热或温病初起的表症未解、里热又盛的病症。应用时常配合连翘、牛蒡子、薄荷等同用;用于疮痈肿毒、咽喉肿痛。金银花清热解毒作用颇强,在外科中为常用之品,一般用于有红肿热痛的疮痈肿毒,对辨证上属于“阳症”的病症,较为适合,可合蒲公英、地丁草、连翘、丹皮、赤芍等煎汤内服,或单用新鲜者捣烂外敷;用于热毒引起的泻痢便血(粪便中夹有黏液和血液)。热毒结聚肠道,入于血分,则下痢便血。银花能凉血而解热毒,故可疗血痢便血,在临床上常以银花炒炭,合黄芩、黄连、白芍、马齿苋等同用。
野菊花,味苦、辛,性微寒;人肺、肝经。具有清热解毒之功效(中药店有售)。可广泛用于下列多种病症。主治预防感冒、宫颈炎(亦可用野菊花注射液局部外涂治疗宫颈炎、阴道炎、外阴溃疡等病)、丹毒(对金黄色葡萄球菌、绿胧杆菌、链球菌等有较强抑制作用)、前列腺炎(该法对急、慢性前列腺炎皆有效)、慢性盆腔炎(具有清热解毒、消肿止痛之效,除个别患者偶有便溏外,无其他副作用)。
枇杷叶,性味苦,微寒。归经归肺、胃经。主治清肺止咳,降逆止呕,用于肺热咳嗽,气逆喘急,胃热呕逆,烦热口渴,清肺气,降肺火,止咳化痰,止吐血呛血,治痈痿热毒。
黄芪,又名黄耆,为豆科草本植物蒙古黄芪、膜荚黄芪的根,具有补气固表、利水退肿、托毒排脓、生肌等功效。黄芪含皂甙、蔗糖、多糖、多种氨基酸、叶酸及硒、锌、铜等多种微量元素。有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。
天丁又名皂荚刺,具抗癌活性,对移植性小鼠肉瘤S-180有抑制作用;药性辛、温;归肝、脾、胃、大肠经;主治败毒抗癌、消肿排脓、治风疗癣。
天葵子性味甘,寒;主治消肿;解毒,利水。治瘰疬,疝气,小便不利。《上海常用中草药》:“清热解毒,利尿。治瘰窃,肿毒,蛇咬伤,尿路结石。”
红花性味辛,温;归经归心、肝经;主治活血通经,散瘀止痛。用于经闭,痛经,恶露不行,症瘕痞块,跌扑损伤,疮疡肿痛。
桃仁性味苦、甘,平;归经归心、肝、大肠经;主治活血祛瘀,润肠通便。用于经闭,痛经,癓瘕痞块,跌扑损伤,肠燥便秘。
水蛭性味咸、苦,平;有小毒;归经归肝经;主治破血,逐瘀,通经。用于症瘕痞块,血瘀经闭,跌扑损伤。
虻虫性味苦,微寒;有毒;主治破瘀散结,痛经堕胎。用于血瘀经闭,跌打损伤。
三棱气平,味苦辛;阴中之阳,破积气、消胀满,通月水,下瘀血。治老癖症瘕结块,妇人血脉不调,心腹刺痛。白者属气,故其色白者,破血中之气;醋煮为良。畏牙硝。孕妇勿用;具有破血行气,消积止痛的功效;用于症瘕痞块,痛经,瘀血经闭,胸痹心痛,食积胀痛。
莪术性味辛、苦,温;归经归肝、脾经;主治行气破血,消积止痛。用于燀瘕痞块,瘀血经闭,食积胀痛;早期宫颈癌。
葛根性味甘、辛,凉;归经归脾、胃经;主治解肌退热,生津,透疹,升阳止泻。用于外感发热头痛、项背强痛,口渴,消渴,麻疹不透,热痢,泄泻;高血压颈项强痛。
甘草性味甘,平;归经归心、肺、脾、胃经;主治补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。
蒲公英性味苦、甘,寒;归经归肝、胃经;主治清热解毒,消肿散结,利尿通淋。用于疔疮肿毒,乳痈,瘰疠,目赤,咽痛,肺痈,肠痈,湿热黄疸,热淋涩痛。
螺内酯能抑制雄性激素的产生,增强睾酮转化为雌二醇。四环素能减弱甘油三酯水解作用,直接参与皮脂腺代谢,降低皮肤表面游离脂肪酸成分。灭滴灵片(甲硝锉)具有较强抗痤疮丙酸杆菌和杀灭毛囊虫的作用。
金银花、野菊花、天丁、葛根、甘草、天葵子、蒲公英、黄芪、枇杷叶具有强大清利肺胃之热,清热解毒的功效。配合灭滴灵片、四环素,具有很强杀灭错装丙酸杆菌和清热泻火解毒的作用。
红花、桃仁、水蛭、虻虫、三棱、莪术,具有活血化瘀,软坚散结的功效。对面部、胸背部的纤维组织,有很好的吸收、阻断、降解的作用。可使皮损的结节、囊肿、瘢痕逆转治愈。
上述药物,中西药配合,配伍严密,相得益彰,几十年的临床检测,1-3个月为一个疗程,疗效确切,显著,适宜推广使用。
综上所述,本发明相较于现有技术的有益效果是:
(1)本发明制得的治疗痤疮的中药组合物,螺内酯能抑制雄性激素的产生,增强睾酮转化为雌二醇。四环素能减弱甘油三酯水解作用,直接参与皮脂腺代谢,降低皮肤表面游离脂肪酸成分。灭滴灵片(甲硝锉)具有较强抗痤疮丙酸杆菌和杀灭毛囊虫的作用,从根部消灭痤疮患处的细菌和毛囊虫,同时抑制雄性激素的产生和促进皮脂腺代谢,不给细菌和毛囊虫提供生长环境和营养,促进皮肤良性循环;
(2)本发明制得的治疗痤疮的中药组合物,金银花、野菊花、天丁、葛根、甘草、天葵子、蒲公英、黄芪、枇杷叶具有强大清利肺胃之热,清热解毒的功效。配合灭滴灵片、四环素,具有很强杀灭错装丙酸杆菌和清热泻火解毒的作用;促进皮肤代谢,排毒养颜、提亮肤色的功效明显,修护肌肤,保持肌肤清新光滑的舒爽感;
(3)本发明制得的治疗痤疮的中药组合物,红花、桃仁、水蛭、虻虫、三棱、莪术,具有活血化瘀,促进代谢,软坚散结的功效;对面部、胸背部的纤维组织,有很好的吸收、阻断、降解的作用;可使皮损的结节、囊肿、瘢痕逆转治愈;修复肌肤、使皮肤恢复如初、平滑紧致;
(4)本发明制得的治疗痤疮的中药组合物,中西药配合,配伍严密,相得益彰,疗效确切,显著,适宜推广使用。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅用以解释本发明,并不用于限定本发明,即所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。
因此,以下提供的本发明的实施例的详细描述并非旨在限制要求保护的本发明的范围,而是仅仅表示本发明的选定实施例。基于本发明的实施例,本领域技术人员在没有做出创造性劳动的前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
本实施例所述的一种治疗痤疮的中药组合物,所述治疗痤疮的中药组合物由包括以下重量份数的原料制成:四环素10份,灭滴灵片10份,螺内酯10份,金银花15份,野菊花15份,枇杷叶10份,黄芩17份,天丁18份,天葵子18份,红花10份,桃仁15份,水蛭15份,虻虫10份,三棱17份,莪术17份,葛根15份,甘草5份,蒲公英25份。
上述的一种治疗痤疮的中药组合物的制作方法包括以下步骤:
(1)选料:选取干净、品质优良的四环素,灭滴灵片,螺内酯,金银花,野菊花,枇杷叶,黄芩,天丁,天葵子,红花,桃仁,水蛭,虻虫,三棱,莪术,葛根,甘草,蒲公英按配比分别称量;
(2)粉碎:将步骤(1)称量后原料分别粉碎,过120目滤网过筛;
(3)制膏:将步骤(2)中筛制的混合物加水煎煮2次,合并煎液、过滤、滤液浓缩成75℃时相对密度为1.2的稠膏;
(4)制粒:将步骤(3)的稠膏分离纯化、干燥,制成颗粒;将所述颗粒混匀,填充胶囊内即制得胶囊剂;或者将所述颗粒喷加炼蜜、混匀,制成小丸即制成丸剂;或者将所述颗粒压制成片剂,包糖衣,即制成片剂。
实施例2
本实施例所述的一种治疗痤疮的中药组合物,所述治疗痤疮的中药组合物由包括以下重量份数的原料制成:四环素20份,灭滴灵片20份,螺内酯20份,金银花25份,野菊花25份,枇杷叶20份,黄芩27份,天丁28份,天葵子28份,红花20份,桃仁25份,水蛭25份,虻虫20份,三棱27份,莪术27份,葛根25份,甘草15份,蒲公英35份。
上述的一种治疗痤疮的中药组合物的制作方法包括以下步骤:
(1)选料:选取干净、品质优良的四环素,灭滴灵片,螺内酯,金银花,野菊花,枇杷叶,黄芩,天丁,天葵子,红花,桃仁,水蛭,虻虫,三棱,莪术,葛根,甘草,蒲公英按配比分别称量;
(2)粉碎:将步骤(1)称量后原料分别粉碎,过140目滤网过筛;
(3)制膏:将步骤(2)中筛制的混合物加水煎煮3次,合并煎液、过滤、滤液浓缩成75℃时相对密度为1.8的稠膏;
(4)制粒:将步骤(3)的稠膏分离纯化、干燥,制成颗粒;将所述颗粒混匀,填充胶囊内即制得胶囊剂;或者将所述颗粒喷加炼蜜、混匀,制成小丸即制成丸剂;或者将所述颗粒压制成片剂,包糖衣,即制成片剂。
实施例3
本实施例所述的一种治疗痤疮的中药组合物,所述治疗痤疮的中药组合物由包括以下重量份数的原料制成:四环素12份,灭滴灵片12份,螺内酯12份,金银花17份,野菊花17份,枇杷叶12份,黄芩17份,天丁20份,天葵子20份,红花12份,桃仁17份,水蛭17份,虻虫12份,三棱19份,莪术19份,葛根17份,甘草7份,蒲公英27份。
上述的一种治疗痤疮的中药组合物的制作方法包括以下步骤:
(1)选料:选取干净、品质优良的四环素,灭滴灵片,螺内酯,金银花,野菊花,枇杷叶,黄芩,天丁,天葵子,红花,桃仁,水蛭,虻虫,三棱,莪术,葛根,甘草,蒲公英按配比分别称量;
(2)粉碎:将步骤(1)称量后原料分别粉碎,过120目滤网过筛;
(3)制膏:将步骤(2)中筛制的混合物加水煎煮2次,合并煎液、过滤、滤液浓缩成75℃时相对密度为1.4的稠膏;
(4)制粒:将步骤(3)的稠膏分离纯化、干燥,制成颗粒;将所述颗粒混匀,填充胶囊内即制得胶囊剂;或者将所述颗粒喷加炼蜜、混匀,制成小丸即制成丸剂;或者将所述颗粒压制成片剂,包糖衣,即制成片剂。
实施例4
本实施例所述的一种治疗痤疮的中药组合物,所述治疗痤疮的中药组合物由包括以下重量份数的原料制成:四环素18份,灭滴灵片18份,螺内酯18份,金银花23份,野菊花23份,枇杷叶18份,黄芩27份,天丁26份,天葵子26份,红花18份,桃仁23份,水蛭23份,虻虫18份,三棱25份,莪术25份,葛根23份,甘草13份,蒲公英33份。
上述的一种治疗痤疮的中药组合物的制作方法包括以下步骤:
(1)选料:选取干净、品质优良的四环素,灭滴灵片,螺内酯,金银花,野菊花,枇杷叶,黄芩,天丁,天葵子,红花,桃仁,水蛭,虻虫,三棱,莪术,葛根,甘草,蒲公英按配比分别称量;
(2)粉碎:将步骤(1)称量后原料分别粉碎,过140目滤网过筛;
(3)制膏:将步骤(2)中筛制的混合物加水煎煮3次,合并煎液、过滤、滤液浓缩成75℃时相对密度为1.6的稠膏;
(4)制粒:将步骤(3)的稠膏分离纯化、干燥,制成颗粒;将所述颗粒混匀,填充胶囊内即制得胶囊剂;或者将所述颗粒喷加炼蜜、混匀,制成小丸即制成丸剂;或者将所述颗粒压制成片剂,包糖衣,即制成片剂。
实施例5
本实施例所述的一种治疗痤疮的中药组合物,所述治疗痤疮的中药组合物由包括以下重量份数的原料制成:四环素15份,灭滴灵片15份,螺内酯15份,金银花20份,野菊花20份,枇杷叶15份,黄芩22份,天丁23份,天葵子23份,红花15份,桃仁20份,水蛭20份,虻虫15份,三棱22份,莪术22份,葛根20份,甘草10份,蒲公英30份。
上述的一种治疗痤疮的中药组合物的制作方法包括以下步骤:
(1)选料:选取干净、品质优良的四环素,灭滴灵片,螺内酯,金银花,野菊花,枇杷叶,黄芩,天丁,天葵子,红花,桃仁,水蛭,虻虫,三棱,莪术,葛根,甘草,蒲公英按配比分别称量;
(2)粉碎:将步骤(1)称量后原料分别粉碎,过130目滤网过筛;
(3)制膏:将步骤(2)中筛制的混合物加水煎煮3次,合并煎液、过滤、滤液浓缩成75℃时相对密度为1.5的稠膏;
(4)制粒:将步骤(3)的稠膏分离纯化、干燥,制成颗粒;将所述颗粒混匀,填充胶囊内即制得胶囊剂;或者将所述颗粒喷加炼蜜、混匀,制成小丸即制成丸剂;或者将所述颗粒压制成片剂,包糖衣,即制成片剂。
病例1
李某某,女,21岁,大学学生,2017年1月就诊。症状:满面通红,额部有数粒大红痘及瘢痕,太阳穴处有6、7粒,左右面颊各有20余粒绿豆大小红痘,发病两年。曾多次外涂其它膏剂、水剂,口服西药等,效果不明显。后服用本发明丸剂1个疗程后,痘消80%,继续服用1个疗程,痊愈,且面色绛红消失、恢复正常面色,至今未复发。
病例2
刘某某,女,25岁,公司职员,2016年12月就诊,满脸都是青春痘,似豌豆大小,伴有脓疱和红肿,面部油腻,额头和鼻子尤其严重,非常痛苦,影响工作;曾服用过多种治疗青春痘的中药、西药等药物,但是都未曾治愈,反复发作。开始使用本发明的丸剂后1个月,脓疱和红肿明显缓解,青春痘收缩;坚持使用至1个疗程完,青春痘基本消失,坚持使用2个疗程,面部红润,皮肤恢复如初、平滑紧致,随访,青春痘没有再发生过。
病例3
谢某某,男,27岁,公司职员,2017年6月就诊,脸颊有5、6粒青春痘,但是有很多之前留下的痘印瘢痕、结节,导致皮肤肤色不均,粗糙;曾擦拭过多种治疗痘印的中药药膏、药用化妆品等,但是效果都不明显。开始使用本发明的丸剂后1个疗程,青春痘消失,痘印变淡;坚持使用至第2个疗程,痘印瘢痕几乎消失,坚持使用第3个疗程,痘印瘢痕、结节完全消失,皮肤恢复如初、平滑紧致,随访,青春痘没有再发生过。
以上所述实施例仅表达了本申请的具体实施方式,其描述较为具体和详细,但并不能因此而理解为对本申请保护范围的限制。应当指出的是,对于本领域的普通技术人员来说,在不脱离本申请技术方案构思的前提下,还可以做出若干变形和改进,这些都属于本申请的保护范围。
Claims (4)
1.一种治疗痤疮的中药组合物,其特征在于:所述治疗痤疮的中药组合物由包括以下重量份数的原料制成:四环素10-20份,灭滴灵片10-20份,螺内酯10-20份,金银花15-25份,野菊花15-25份,枇杷叶10-20份,黄芩17-27份,天丁18-28份,天葵子18-28份,红花10-20份,桃仁15-25份,水蛭15-25份,虻虫10-20份,三棱17-27份,莪术17-27份,葛根15-25份,甘草5-15份,蒲公英25-35份。
2.根据权利要求1所述的一种治疗痤疮的中药组合物,其特征在于:所述治疗痤疮的中药组合物由包括以下重量份数的原料制成:四环素12-18份,灭滴灵片12-18份,螺内酯12-18份,金银花17-23份,野菊花17-23份,枇杷叶12-18份,黄芩17-27份,天丁20-26份,天葵子20-26份,红花12-18份,桃仁17-23份,水蛭17-23份,虻虫12-18份,三棱19-25份,莪术19-25份,葛根17-23份,甘草7-13份,蒲公英27-33份。
3.根据权利要求2所述的一种治疗痤疮的中药组合物,其特征在于:所述治疗痤疮的中药组合物由包括以下重量份数的原料制成:四环素15份,灭滴灵片15份,螺内酯15份,金银花20份,野菊花20份,枇杷叶15份,黄芩22份,天丁23份,天葵子23份,红花15份,桃仁20份,水蛭20份,虻虫15份,三棱22份,莪术22份,葛根20份,甘草10份,蒲公英30份。
4.一种权利要求1~3任一项所述的治疗痤疮的中药组合物的制作方法,其特征在于,包括以下步骤:
(1)选料:选取干净、品质优良的四环素,灭滴灵片,螺内酯,金银花,野菊花,枇杷叶,黄芩,天丁,天葵子,红花,桃仁,水蛭,虻虫,三棱,莪术,葛根,甘草,蒲公英按配比分别称量;
(2)粉碎:将步骤(1)称量后原料分别粉碎,过120-140目滤网过筛;
(3)制膏:将步骤(2)中筛制的混合物加水煎煮2-3次,合并煎液、过滤、滤液浓缩成75℃时相对密度为1.2-1.8的稠膏;
(4)制粒:将步骤(3)的稠膏分离纯化、干燥,制成颗粒;将所述颗粒混匀,填充胶囊内即制得胶囊剂;或者将所述颗粒喷加炼蜜、混匀,制成小丸即制成丸剂;或者将所述颗粒压制成片剂,包糖衣,即制成片剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811008923.6A CN108704109A (zh) | 2018-08-31 | 2018-08-31 | 一种治疗痤疮的中药组合物及其制作方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811008923.6A CN108704109A (zh) | 2018-08-31 | 2018-08-31 | 一种治疗痤疮的中药组合物及其制作方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108704109A true CN108704109A (zh) | 2018-10-26 |
Family
ID=63873580
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811008923.6A Pending CN108704109A (zh) | 2018-08-31 | 2018-08-31 | 一种治疗痤疮的中药组合物及其制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108704109A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103550683A (zh) * | 2013-10-26 | 2014-02-05 | 荣成市科学技术情报研究所 | 一种治疗痤疮的中药组合物 |
-
2018
- 2018-08-31 CN CN201811008923.6A patent/CN108704109A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103550683A (zh) * | 2013-10-26 | 2014-02-05 | 荣成市科学技术情报研究所 | 一种治疗痤疮的中药组合物 |
Non-Patent Citations (4)
Title |
---|
刘叶兰等: "寻常痤疮分阶段论治的临床体会", 《甘肃中医》 * |
吴欢欢等: "痤疮发病机制及药物治疗进展", 《中国医药科学》 * |
曹青霞: "中西医结合治疗女性面部痤疮60例", 《中医研究》 * |
祁永华等: "痤疮治疗研究进展 ", 《亚太传统医药》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102631413B (zh) | 一种治疗痤疮的中药组合物 | |
CN104225441A (zh) | 一种治疗胃病的中药组合物及其颗粒剂和胶囊剂的制备方法 | |
CN104524337A (zh) | 一种治疗口腔溃疡的中药 | |
CN104873705A (zh) | 一种治疗冠心病心绞痛的药物组合物及其应用 | |
CN101164600A (zh) | 一种治疗痤疮、青春痘的药物 | |
CN102302690B (zh) | 一种治疗放射性直肠炎的中药 | |
CN101239162B (zh) | 一种治疗胃病的中药组合物 | |
CN103610934B (zh) | 一种治疗咽炎的中药 | |
CN103417923A (zh) | 一种治疗消化性溃疡的药物 | |
CN106267098A (zh) | 一种可有效治疗痛风的中药组合物及其制备方法 | |
CN102580032B (zh) | 具有促排石作用的中药组合物片剂、散剂、口服液及制备方法 | |
CN108704109A (zh) | 一种治疗痤疮的中药组合物及其制作方法 | |
CN104225382A (zh) | 一种治疗暗疮的中药 | |
CN103845547A (zh) | 用于治疗流行性腮腺炎的中药汤剂 | |
CN107854662A (zh) | 一种治疗肝硬化腹水的中药制剂及其制备方法 | |
CN104127765B (zh) | 一种治疗皮肤癣的滴剂及其制备方法 | |
CN105998781A (zh) | 一种治疗急性胃肠炎的药物组合物 | |
CN105434745A (zh) | 一种治疗过敏性紫癜的药物组合物 | |
CN104940777A (zh) | 一种治疗肝旺脾弱型经行泄泻的冲剂及其制备方法 | |
CN104721786A (zh) | 一种治疗妊娠肝内胆汁淤积症的中药制剂及其制备方法 | |
CN104225009A (zh) | 一种治疗腹泻的中药组合物 | |
CN103800742A (zh) | 一种全部以药食同源药材制备的祛痘组合物 | |
CN104107374A (zh) | 一种用于治疗宫颈糜烂的中药胶囊及其制备方法 | |
CN104096099A (zh) | 治疗复发性口腔溃疡的中药组合物 | |
CN103816412A (zh) | 一种治疗耳源性脑脓肿的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181026 |
|
RJ01 | Rejection of invention patent application after publication |